Utilization of histamine receptor h3 gene participating in body weight or food intake control
To clarify histamine receptor H3 protein function in vivo, the present inventors constructed a nonhuman higher animal in which the expression of a histamine receptor H3 gene was artificially inhibited. As a result, the present inventors found that this nonhuman higher animal showed increased body we...
Gespeichert in:
Hauptverfasser: | , , |
---|---|
Format: | Patent |
Sprache: | eng |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | Kotani, Hidehito Takahashi, Kazuhiko Suwa, Hiroaki |
description | To clarify histamine receptor H3 protein function in vivo, the present inventors constructed a nonhuman higher animal in which the expression of a histamine receptor H3 gene was artificially inhibited. As a result, the present inventors found that this nonhuman higher animal showed increased body weight, food intake, blood insulin level, or blood leptin level compared with a control. Thus, the present inventors found that abnormalities in the histamine receptor H3 protein relate to diseases characterized by changes in body weight or food intake, and this has made it possible to screen drugs for treatment or prevention of these diseases, and to examine these diseases. |
format | Patent |
fullrecord | <record><control><sourceid>uspatents_EFH</sourceid><recordid>TN_cdi_uspatents_grants_07767881</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>07767881</sourcerecordid><originalsourceid>FETCH-uspatents_grants_077678813</originalsourceid><addsrcrecordid>eNqNjEEKAjEMAHvxIOof8gFBWbB7F8UH6FEkdtNusDaljYi-3go-wNPAMMzUnE_Kkd-oLAnEw8hV8c6JoJCjrFJg7CBQExmLsuPc2hSAE1xleMGTOIwKrfMiQ9OKNwInSYvEuZl4jJUWP84M7HfH7WH5qG1DSeslFPxiZe3G9v26-yP5ALn9PT0</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Utilization of histamine receptor h3 gene participating in body weight or food intake control</title><source>USPTO Issued Patents</source><creator>Kotani, Hidehito ; Takahashi, Kazuhiko ; Suwa, Hiroaki</creator><creatorcontrib>Kotani, Hidehito ; Takahashi, Kazuhiko ; Suwa, Hiroaki ; Banyu Pharmaceutical Co., Ltd</creatorcontrib><description>To clarify histamine receptor H3 protein function in vivo, the present inventors constructed a nonhuman higher animal in which the expression of a histamine receptor H3 gene was artificially inhibited. As a result, the present inventors found that this nonhuman higher animal showed increased body weight, food intake, blood insulin level, or blood leptin level compared with a control. Thus, the present inventors found that abnormalities in the histamine receptor H3 protein relate to diseases characterized by changes in body weight or food intake, and this has made it possible to screen drugs for treatment or prevention of these diseases, and to examine these diseases.</description><language>eng</language><creationdate>2010</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/7767881$$EPDF$$P50$$Guspatents$$Hfree_for_read</linktopdf><link.rule.ids>230,308,777,799,882,64018</link.rule.ids><linktorsrc>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/7767881$$EView_record_in_USPTO$$FView_record_in_$$GUSPTO$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Kotani, Hidehito</creatorcontrib><creatorcontrib>Takahashi, Kazuhiko</creatorcontrib><creatorcontrib>Suwa, Hiroaki</creatorcontrib><creatorcontrib>Banyu Pharmaceutical Co., Ltd</creatorcontrib><title>Utilization of histamine receptor h3 gene participating in body weight or food intake control</title><description>To clarify histamine receptor H3 protein function in vivo, the present inventors constructed a nonhuman higher animal in which the expression of a histamine receptor H3 gene was artificially inhibited. As a result, the present inventors found that this nonhuman higher animal showed increased body weight, food intake, blood insulin level, or blood leptin level compared with a control. Thus, the present inventors found that abnormalities in the histamine receptor H3 protein relate to diseases characterized by changes in body weight or food intake, and this has made it possible to screen drugs for treatment or prevention of these diseases, and to examine these diseases.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2010</creationdate><recordtype>patent</recordtype><sourceid>EFH</sourceid><recordid>eNqNjEEKAjEMAHvxIOof8gFBWbB7F8UH6FEkdtNusDaljYi-3go-wNPAMMzUnE_Kkd-oLAnEw8hV8c6JoJCjrFJg7CBQExmLsuPc2hSAE1xleMGTOIwKrfMiQ9OKNwInSYvEuZl4jJUWP84M7HfH7WH5qG1DSeslFPxiZe3G9v26-yP5ALn9PT0</recordid><startdate>20100803</startdate><enddate>20100803</enddate><creator>Kotani, Hidehito</creator><creator>Takahashi, Kazuhiko</creator><creator>Suwa, Hiroaki</creator><scope>EFH</scope></search><sort><creationdate>20100803</creationdate><title>Utilization of histamine receptor h3 gene participating in body weight or food intake control</title><author>Kotani, Hidehito ; Takahashi, Kazuhiko ; Suwa, Hiroaki</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-uspatents_grants_077678813</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2010</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Kotani, Hidehito</creatorcontrib><creatorcontrib>Takahashi, Kazuhiko</creatorcontrib><creatorcontrib>Suwa, Hiroaki</creatorcontrib><creatorcontrib>Banyu Pharmaceutical Co., Ltd</creatorcontrib><collection>USPTO Issued Patents</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Kotani, Hidehito</au><au>Takahashi, Kazuhiko</au><au>Suwa, Hiroaki</au><aucorp>Banyu Pharmaceutical Co., Ltd</aucorp><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Utilization of histamine receptor h3 gene participating in body weight or food intake control</title><date>2010-08-03</date><risdate>2010</risdate><abstract>To clarify histamine receptor H3 protein function in vivo, the present inventors constructed a nonhuman higher animal in which the expression of a histamine receptor H3 gene was artificially inhibited. As a result, the present inventors found that this nonhuman higher animal showed increased body weight, food intake, blood insulin level, or blood leptin level compared with a control. Thus, the present inventors found that abnormalities in the histamine receptor H3 protein relate to diseases characterized by changes in body weight or food intake, and this has made it possible to screen drugs for treatment or prevention of these diseases, and to examine these diseases.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng |
recordid | cdi_uspatents_grants_07767881 |
source | USPTO Issued Patents |
title | Utilization of histamine receptor h3 gene participating in body weight or food intake control |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T02%3A09%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-uspatents_EFH&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Kotani,%20Hidehito&rft.aucorp=Banyu%20Pharmaceutical%20Co.,%20Ltd&rft.date=2010-08-03&rft_id=info:doi/&rft_dat=%3Cuspatents_EFH%3E07767881%3C/uspatents_EFH%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |